# EDGAR Filing Document

**Accession Number:** 0001875558
**File Stem:** 0001104659-26-017097
**Filing Date:** 2026-2
**Character Count:** 1997
**Document Hash:** 9788c85b0757a4e80c530b1f987ba47b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-017097.hdr.sgml**: 20260320

**ACCESSION NUMBER**: 0001104659-26-017097

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260218

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nuvectis Pharma, Inc.
- **CENTRAL INDEX KEY:** 0001875558
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 862405608
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1 BRIDGE PLAZA, SUITE 275
- **CITY:** FORT LEE
- **STATE:** NJ
- **ZIP:** 07024
- **BUSINESS PHONE:** 360-837-7232

**MAIL ADDRESS:**
- **STREET 1:** 1 BRIDGE PLAZA, SUITE 275
- **CITY:** FORT LEE
- **STATE:** NJ
- **ZIP:** 07024

![](tm266190d3_corresp-img01.jpg)

February 18, 2026

**<u>VIA EDGAR</u>**

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Nuvectis Pharma, Inc.<br> Registration Statement on Form S-3** |
|  | **File No. 333-293459** |

---

Ladies and Gentlemen:

Nuvectis Pharma, Inc. (the "Company") hereby requests, pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:30 p.m. EST on February 20, 2026, or as soon thereafter as practicable.

Please contact Matt Mamak of Alston & Bird LLP, the Company's counsel, at (212) 210-1256, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

---

| | |
|:---|:---|
| **Nuvectis Pharma, Inc.** | **Nuvectis Pharma, Inc.** |
| By: | *<u>/s/ Ron Bentsur</u>* |
| Name: | Ron Bentsur |
| Title: | Chairman, Chief Executive Officer and President |

---